Ensoma company information, Employees & Contact Information

Ensoma Announces $53 Million Financing to Support Key Clinical Milestones for EN-374 and Continued Development of In Vivo Hematopoietic Stem Cell Engineering Pipeline Yahoo Finance

Ensoma Announces FDA Clearance of IND Application for First In Vivo HSC-Directed Gene Insertion Therapy Business Wire

Ensoma to Present New Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting BioSpace

Avenzo, Ensoma each add over $50M to their coffers FirstWord Pharma

Ensoma: $53 Million Secured To Advance Stem Cell Therapies And Global Clinical Impact Pulse 2.0

FDA clears Ensoma’s application for rare genetic disorder treatment Pharmaceutical Technology

$50M+ rounds for Avenzo, AusperBio, Ensoma, Sparrow: Venture Report BioCentury

Ensoma Raises $53M in Funding FinSMEs

Ensoma to Present Preclinical Data and Manufacturing Advancements for In Vivo HSC Engineering Platform to Treat Cancer, Immune Disorders and Genetic Diseases at ASGCT 28th Annual Meeting BioSpace

Ensoma Appoints Jon Garen as Chief Corporate Development and Business Officer citybiz

Precision CRISPR for in vivo genome engineering Nature

Ensoma acquiring Twelve Bio Labiotech.eu

Jim Burns reunites with Genzyme colleague at Ensoma; Lilly exec to retire after 27 years Endpoints News

Ensoma buys a startup to advance ‘in vivo’ cell therapy work BioPharma Dive

EN-374 granted rare pediatric disease, orphan drug designations for chronic granulomatous disease Contemporary Pediatrics

Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines Fierce Biotech

Ensoma Closes Series B Extension, Bringing Total Round to $135 Million Business Wire

Ensoma and Interius BioTherapeutics: in vivo veritas Nature

Ensoma Announces Closing of Twelve Bio Acquisition Business Wire

Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines Business Wire

Ensoma next stop for company builder Jim Burns The Pharma Letter

Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines CRISPR Medicine News

Fred Hutch, Univ. of Washington biotech spinout Ensoma launches with $70M in funding GeekWire

Ensoma Taps Gene Therapy Leader as First CEO BioSpace

Takeda selects former CRISPR Therapeutics CMO to lead oncology unit; Emile Nuwaysir out at Ensoma Endpoints News

The Big Deal: Ensoma tops off a bumper week for pharma - Global Corporate Venturing

He led Bayer's $1B Parkinson's bet. Now, Nuwaysir will helm Takeda-partnered Ensoma Fierce Biotech

Ensoma Launches with $70 Million Series A and Takeda Licensing Deal BioSpace

A new startup gets Takeda’s backing to take complex genetic medicines ‘off the shelf’ BioPharma Dive

Danish startup with CRISPR diagnostic technology is acquired by Boston-based genomic medicines company - ArcticStartup

How biotech startup Ensoma aims to take gene therapy beyond rare diseases MedCity News

ENTERTAINMENT: Fiesta en SoMa, HarvestFest set; library to grandly reopen The Arkansas Democrat-Gazette

'Slow Down SoMa' | Little Rock traffic-calming project being installed ahead of Fiesta En SoMa thv11.com

Fiesta en SoMa returning to Little Rock to celebrate Hispanic Heritage Month kark.com

Boston biotech Ensoma lands $70m in funding, partnership with Takeda The Boston Globe

Ensoma acquires Danish CRISPR university spin-off medwatch.com